主要文件

查看所有文档

21172

氢化钙

Name: 氢化钙
Brand: SIAL

purum, ≥95.0% (gas-volumetric)

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

H₂Ca

化学文摘社编号:

7789-78-8

分子量:

42.09

EC Number:

232-189-2

UNSPSC Code:

12352300

MDL number:

MFCD00010897

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

grade

purum

assay

≥95.0% (gas-volumetric)

reaction suitability

reagent type: reductant

mp

816 °C (lit.)

SMILES string

[Ca]

InChI

1S/Ca.2H

InChI key

FAQLAUHZSGTTLN-UHFFFAOYSA-N

说明

Still not finding the right product?

Explore all of our products under 氢化钙

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Zhichao Liu et al.

PLoS computational biology, 7(12), e1002310-e1002310 (2011-12-24)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI types (hepatotoxic side effects) seen in the clinic can be translated